Results 121 to 130 of about 3,433 (145)

[Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors]. [PDF]

Probl Endokrinol (Mosk), 2023
Voytko MS, Klimontov VV, Pospelova TI, Shebunyaeva YY, Fazullina ON.   +4 more
europepmc   +1 more source

[Combination of Klinefelter syndrome and the classic form of congenital dysfunction of the adrenal cortex: clinical observation]. [PDF]

Probl Endokrinol (Mosk)
Volkova NI, Davidenko IY, Stavitskaya DP, Kudinova EV.   +3 more
europepmc   +1 more source

[The relationship between Parkinson's disease and metabolic disorders: the impact of systemic dysfunctions on neurodegeneration]. [PDF]

Probl Endokrinol (Mosk)
Yusupov FA, Abdykadyrov MS.
europepmc   +1 more source

[Regional target program «Prevention of iodine deficiency diseases for 202X-202X»]. [PDF]

Probl Endokrinol (Mosk), 2022
Troshina EA, Platonova NM, Makolina NP, Belovalova IM, Senyushkina ES, Melnichenko GA, Dedov II.   +6 more
europepmc   +1 more source

Оценка факторов окружающей среды на заболеваемость населения северных районов Республики Дагестан

The article presents data on the quality of drinking water and air and the impact on the dental morbidity of the population of the cities of ecological well-being (Khasavyurt) and disadvantage (Kizlyar).В статье представлены данные по качеству питьевой ...
Косырева Т.Ф., Османов И.Н., Османова Ф.И.   +2 more
core  

[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma]. [PDF]

Probl Endokrinol (Mosk)
Astafyeva LI, Kalinin PL, Trunin YY, Kobyakov GL, Sidneva YG.   +4 more
europepmc   +1 more source

РАСТИТЕЛЬНЫЕ ПРЕПАРАТЫ КАК ПОТЕНЦИАЛЬНЫЕ ПРОТИВОВИРУСНЫЕ СРЕДСТВА ДЛЯ ЛЕЧЕНИЯ SARS-COV-2 ИНФЕКЦИИ. [PDF]

Paemi Sino, 2022
Душенков B, Душенкова A.   +1 more
europepmc   +1 more source

ПЕРВИЧНАЯ ЗАБОЛЕВАЕМОСТЬ УЧАСТНИКОВ ЛИКВИДАЦИИ ПОСЛЕДСТВИЙ ЧЕРНОБЫЛЬСКОЙ АВАРИИИ

, 2017
This paper is devoted to results of comparative analysis of primarily morbidity in two groups of recovery workers of Chernobyl Accident in a period from 1986 up to 2005 years.
V. N. Nurlanov, В. Н. Нуралов, И. Э. Бронштейн, I. A. Bronstein, Т. М. Королева, T. M. Koroleva   +5 more
core  

Target product profile: <i>Trypanosoma brucei gambiense</i> test for low-prevalence settings. [PDF]

Bull World Health Organ, 2023
Priotto G, Franco JR, Lejon V, Büscher P, Matovu E, Ndung'u J, Biéler S, Mumba D, Van Reet N, Verlé P, Jamonneau V, Simarro PP, Ebeja AK, Sankara D, Dagne DA.   +14 more
europepmc   +1 more source

[Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms]. [PDF]

Probl Endokrinol (Mosk)
Dvoryanchikov YV, Deunezhewa SM, Yatskov IA, Beloglazov VA.   +3 more
europepmc   +1 more source